• 1
    Acheson KJ, Zahorska-Markiewwicz B., Pittett Ph, Jaquiér E. Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals. Am J Clin Nutr. 1980; 33: 989997.
  • 2
    Alger S., Larson K., Boyce VL, et al. Effect of phenylpropanolamine on energy expenditure and weight loss in overweight women. Am J Clin Nutr. 1993; 57: 120126.
  • 3
    Anderson KM, Kannell WB. Obesity and disease. In: Björntorp P., Brodoff BN, eds. Obesity. Philadelphia: J.B. Lippincott Company; 1992; 465T73.
  • 4
    Arch JR, Ainsworth AT, Cawthorne MA. Thermogenic and anorectic effects of ephedrine and cogeners in mice and rats. Life Sci. 1982; 30: 18171826.
  • 5
    Blaza S., Garrow JS. Thermogenic response to temperature, exercise and food stimuli in lean and obese women, studied by 24-h direct calorimetry. Br J Nutr. 1983; 49: 171180.
  • 6
    French SN. Nutritional Assessment via Indirect Calorimetry. Tech Notes. St. Paul, MN: Medical Graphics Corporation; 1987.
  • 7
    Greenway FL. Clinical studies with phenylpropanolamine: A metaanalysis. Am J Clin Nutr. 1992; 55: 203S205S.
  • 8
    Hoebel BG, Cooper J., Kamin MC, Willard D. Appetite suppression by phenylpropanolamine in humans. Obesity/ Bariatric Med. 1975; 4: 192197.
  • 9
    Isbell TR, Klesges RC, Meyers AW, Klesges LM. Measurement reliability and reactivity using repeated measurements of resting energy expenditure with a face mask, mouthpiece, and ventilated canopy. J Parenter Enter Nutr. 1991; 15: 165168.
  • 10
    Lasagna L. Phenylpropanolamine: A Review. New York: Wiley; 1988.
  • 11
    Metropolitan Life Insurance Company. Metropolitan height and weight tables. Stat Bull Met Life Insur Co. 1983; 64: 2.
  • 12
    Ravussin E., Bogardus C. Relationship of genetics, age and physical fitness to daily energy expenditure and fuel utilization. Am J Clin Nutr. 1989; 49: 968975.
  • 13
    Rushing PA, Winders SE, Mittleman G. Effects of phenylpropanolamine infusion and withdrawal on body weight and dietary composition in male and female rats. Physiol Behav. 1993; 54: 523530.
  • 14
    Segal KR, Gutin B., Albu J., Pi-Sunyer FX. Thermic effects of food and exercise in lean and obese men of similar lean body mass. Am J Physiol. 1987; 252: E110E117.
  • 15
    Van Itallie TB. Health implications of overweight and obesity in the United States. Ann Intern Med. 1985; 103: 983988.
  • 16
    Wadden TA, Stunkard AJ. Social and psychological consequences of obesity. Ann Intern Med. 1985; 103: 10621067.
  • 17
    Weintraub M. Phenylpropanolamine as an anorexic agent in weight control: A review of published and unpublished articles. In: Morgan J., Kagan D., Brody J., eds. Phenylpropanolamine: Risks, Benefits, and Controversies. Philadelphia: Praeger Publishers; 1985; 5379.
  • 18
    Wellman PJ. Influence of dl-phenylpropanolamine on brown adipose tissue thermogenesis in the adult rat. Physiol Psychol. 1984; 12: 307310.
  • 19
    Wellman PJ. A review of the physiological bases of the anorexic action of phenylpropanolamine (d, 1-norephedrine). Neurosci Biobehav Rev. 1990; 14: 339355.
  • 20
    Wellman PJ, Sellers TL. Weight loss induced by chronic phenylpropanolamine: Anorexia and brown adipose thermogenesis. Pharmacol Biochem Behav. 1986; 24: 605611.
  • 21
    Winders SE, Amos JC, Wilson MR, Rushing PA, Dykstra T., Coday MC. Effects of chronic phenylpropanolamine administration and termination on body weight and food and water consumption in rats. Psychopharmacology. 1994; 114: 513519.